Stocktoria
Camp4 Therapeutics Corp CAMP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-10-11
Camp4 Therapeutics Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | -1502.4% | -8142.3% | -14822.6% |
| Net margin | -2298.5% | -7943.4% | -14083.1% |
| FCF margin | -852.8% | -7055.7% | -12809.4% |
| Return on assets | -68.2% | -66.1% | -89.7% |
| Return on equity | -168.5% | -82.0% | 39.8% |
| Current ratio | 7.35 | 6.92 | 5.13 |
| Revenue growth | 436.5% | 86.3% | — |
Source: SEC EDGAR filings · CIK 0001736730 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.